Mohammed El-Kurdi, PhD, Vice President for Tissue Science, and Luc Verhees, Senior Vice President for Clinical, Pre-clinical and Medical Affairs, joined Acting CEO Eliane Schutte - Xeltis CDO since 2016 - and CTO and Co-founder [...]
An abstract on Xeltis clinical data has been shortlisted as one of five finalists at the EACTS Techno-College Innovation Award. Professor Tomasz Mroczek from the Children’s University Hospital, Krakow, Poland will present 1-year Xeltis data [...]
Initial in vivo experience on Xeltis’ restorative aortic valve will feature as one of the highest peer-reviewed oral abstracts of TCT 2018. Professor Christian Spaulding, Chief, Interventional Cardiology, European Hospital Georges Pompidou, Paris (F), will [...]
Preclinical data on Xeltis’ restorative heart valve technology will feature at the 16th International Society of Applied Cardiovascular Biology (ISACB) Biennial meeting. Professor Frederick J. Schoen from Harvard Medical School will present 1-year preclinical data [...]
The Children’s Hospital Colorado has joined other prominent U.S. pediatric centers in the Xplore-2 clinical research study, the first medical center in the Mountain States to take part in the trial. The medical institutions already enrolling [...]
The Children’s Hospital of Pittsburgh of UPMC joined other prominent U.S. centers taking part in the Xplore-2 clinical trial. The medical institutions that may enroll patients in the Xplore-2 Early Feasibility Study include: Boston Children’s [...]
Children’s Hospital Los Angeles (CHLA) recently joined other prominent U.S. pediatric centers in the Xplore-2 clinical research study. The medical institutions that may enroll patients in the Xplore-2 Early Feasibility Study also include: Boston [...]
The potential for Xeltis’ restorative technology in aortic valves will be showcased at the International Society for Minimally Invasive Cardiothoracic Surgery meeting in Vancouver on June 13-16. Doctor Gregory Fontana, CardioVascular Institute Los Robles [...]
Preliminary one-year data from the Xplore-1 clinical trial have shown that Xeltis’ restorative pulmonary heart valve has potential for use in RVOT reconstruction. In a presentation at the ECHSA meeting in Cascais, Portugal, trial investigator [...]
Preliminary one-year data from the Xplore-1 clinical trial, evaluating Xeltis’ restorative pulmonary heart, valve will be presented for the first time at the ECHSA meeting in Cascais, Portugal. Trial investigator Professor Tomasz Mroczek from the [...]
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.